7 Stocks Riding the Government's Hidden $5 Billion AI Bet

Note: Prefer to enjoy this in video form? Check out our YouTube video on the same topic.

Recently, 15 federal agencies and dozens of companies signed onto a program that touches nuclear power, semiconductors, quantum computing, and biotech, all at once. The number attached to it is $5 billion. And unless you follow energy policy for a living, you've probably never heard of it.

A note from our sponsors...

An urgent warning for all U.S. Investors...

"Will You Be On The Right Side Of the Great AI Divide?"

Legendary investment strategist from America's oldest and largest private investment research club bought (split-adjusted) Apple at $1... Netflix at $1.62... Amazon under $2.

Now he's speaking out about 3 AI super-cycle stocks that could dominate the markets.

GET THE FULL STORY HERE

It's called the Genesis Mission. Below, I’ll explain what’s happening then walk you through 7 stocks poised to benefit, with a full review of which ones are actually worth your time based on the underlying data. 

4 of them are already building the actual infrastructure this program runs on. 3 more are lesser-known names flying under the radar. And the last one you'll never see coming. Hint: it's not an AI company at all. We'll help you connect the dots.

But first… 

What Is the Genesis Mission?

The Genesis Mission started as a November 2025 executive order: point the Department of Energy's 17 national labs — Argonne, Oak Ridge, Los Alamos — and serious AI compute at hard science problems like nuclear fission and fusion, critical materials, semiconductors, and quantum information.

For most of this year it looked like a modest $293 million grant program. Then, in the past few weeks, that changed overnight — and for investors paying attention, this is where it gets interesting.

The Stats, Unpacked

At the first-ever Genesis Mission Summit, the White House unveiled more than $5 billion in new federal commitments. It's now 15-plus agencies — DOE, NASA, the National Science Foundation, and the NIH, which committed $1.2 billion of its own money to a "Bio Genesis Mission" for AI-driven biomedical research. The DOE also confirmed over $800 million in committed private-partner support.

The scale-up has been fast: that original $293 million program drew more than 5,000 applications, but DOE could only fund 278 — a sub-6% acceptance rate, spanning all 50 states and 342 institutions.

So this is real money moving right now. The question is who's on the other end of those checks — and a handful of public companies have already been named, including one quietly ranked in the top 4% of our quant ratings database.

Who's Actually Building This

Two flagship supercomputer clusters are being built to run all this. At Argonne, a cluster called Equinox — roughly 10,000 of Nvidia's Blackwell chips — is being built by Nvidia and Oracle, targeting full operation this year.

So when people ask who actually gets paid when the government spends $5 billion on AI, this is the answer. Let's scan the data behind this first buildout.

ORACLE (ORCL)

Oracle (ORCL) sits at a C in our Zen Ratings, a Hold recommendation. That grade is reached at the end of a 115-factor review, which evaluates things like Value, Momentum, Sentiment, and more, plus 7 underlying Component Grades.

Oracle has a genuinely flat profile, with every single component grade landing at C. Our Editor-in-Chief likes to joke that C's are short for "C ya later" — not exactly something you should be in a rush to buy.

Wall Street analysts see it differently, with the 27 analysts covering Oracle landing on a consensus Strong Buy recommendation and an average price target of over 100% above current levels as of this writing. But when the sell-side and the fundamentals split this dramatically, the data has historically been the safer call.

Nvidia (NVDA) 

Nvidia (NVDA), on the other hand, comes into this list with a Zen Rating of B, a Buy recommendation. Its Component Grades are generally strong, with its standout area being Financials, graded A. It's worth noting it receives a D for Safety — not unusual for the AI and semiconductor space, but still a risk worth respecting.

Wall Street analysts back the case here, with the 25 analysts covering Nvidia settling on a consensus Strong Buy recommendation and an average price target roughly 60% higher than current levels as of this writing.

So that was the first buildout. The second is Oak Ridge National Laboratory in Tennessee, where there's a comparable cluster called Lux, being built by Advanced Micro Devices (AMD) and Hewlett Packard Enterprise. It's running AMD's latest Instinct chips alongside HPE's server hardware, also targeting this year.

Advanced Micro Devices (AMD)

Let's run the numbers for these. AMD is also a B, a Buy recommendation, with solid grades across Growth, Momentum, and Sentiment. A little ironic for a company building AI infrastructure, its weakest component is actually AI, graded D — worth noting that this grade isn't tied to how much AI a company does, but to our own algorithm that detects patterns tied to outperformance.

Wall Street analysts are firmly on the bullish side, with the 34 analysts covering AMD landing on a consensus Strong Buy recommendation and price targets stretching as high as over 40% above current levels.

Hewlett Packard Enterprise (HPE) 

But Hewlett Packard Enterprise (HPE) is the standout of the four stocks mentioned so far. It's an A, a Strong Buy, with top A grades in both Growth and Sentiment. Wall Street analysts agree the stock has room to run, with the 16 analysts covering HPE settling on a consensus Buy recommendation and some 1-year price targets going higher than 60% above today's levels.

By the way, these Zen Ratings and Component Grades are updated daily, so for the most up-to-date information, visit wallstreetzen.com and enter the ticker you're interested in.

The Broader List — And the Actionable Take

Nvidia, Oracle, AMD, and HPE are the clearest names because they have actual named infrastructure contracts.

But the full consortium is much bigger than the 24 companies that signed on back in December. It now includes Microsoft, Google, Amazon, IBM, Intel, Dell, Palantir, CoreWeave, and dozens of smaller specialists in quantum computing and critical materials.

Here's the thing to be honest about: this is not a one-day pop story. There is no single earnings call where "Genesis Mission" shows up and the stock jumps 10 percent. This is a multi-year federal infrastructure build-out — think of it the same way you would track a highway bill or a defense program.

Phase II awards, the bigger ones, at $6 million to $15 million each, are expected in the months ahead. That's your next checkpoint. So the question isn't which of these stocks pops tomorrow. It's which of these names show real quality underneath the news.

Now let's look at a few of the less obvious ones on our system.

CoreWeave (CRWV)

We'll start with a caution. CoreWeave (CRWV) is named as a consortium partner here, and on paper that sounds like exactly the kind of smaller name that benefits most.

But on our system, CoreWeave currently carries an F, a Strong Sell recommendation. It sits in the bottom 1% of all stocks based on its fundamentals. Its Financials grade is F, in the bottom 3%. Its Sentiment grade is F, in the bottom 2%. A government contract does not cancel that out. The news is real, but it does not override what the underlying numbers say about a stock today.

Here's what makes this even more of a caution flag: Wall Street analysts are actually bullish on CoreWeave, with one price target suggesting the stock could see greater than 250% upside from current levels as of this writing. When even that sell-side optimism can't move our system off a Strong Sell, that tells you the fundamental data is pretty loud.

Amentum (AMTM) 

Next up is Amentum (AMTM), a much smaller government-services company recently selected to build an AI data center and energy project at the Savannah River site for the National Nuclear Security Administration. That's the kind of contract that moves the needle for a company that size a lot more than it does for Nvidia.

Its Zen Rating sits at a C, a Hold recommendation, in the top 25% of stocks. Its clear standout is Value, in the top 4%, so the valuation is attractive, but the overall grade suggests caution — and that there could be better A or B picks out there. Wall Street analysts land a hair more optimistic than our system does, with the 7 analysts covering Amentum settling on a consensus Buy recommendation and an average price target implying upside of nearly 40% above current levels.

John Wiley & Sons (WLY)

And then there's the one nobody expected: John Wiley & Sons (WLY). Yes, the academic publisher. Wiley joined recently to bring its research database into the mix, because a lot of scientific AI work needs high-quality training data, and Wiley has decades of it.

In our system, Wiley carries a Zen Rating of A, a Strong Buy recommendation, and ranks in the top 4% of all stocks. Its standout component is Financials, in the top 2%, and it's the number 1 ranked stock in its entire industry group. 

There aren't currently any price target forecasts on Wiley from Wall Street analysts, but the two analysts who do follow the stock forecast a high return on equity of around 25% over the next two years — a sign of efficient capital use that lines up cleanly with the Financials grade our system is already flagging.

Nobody watches AI headlines and lands on the academic publishing sector. That's what makes this one interesting.

Conclusion

So there you have it. A huge project that brings together some of the biggest trends moving stocks today, all in one place. 

By the way, if you like stock talk like this, WallStreetZen's no-cost Live training sessions are worth a look. Join our Editor-in-Chief Steve Reitmeister on Monday at 7pm EST — he doesn't just talk about what he's buying, but how he's finding stocks so you can do the same in the days ahead, plus his Trade of the Week combining the Zen Ratings with his own investing track record. Register for free at wallstreetzen.com/live.

What to Do Next?

• 77 Best Stocks NOW! >
• Options Trading with the Zen Ratings >
• 2 New Stocks to Buy from Steve Reitmeister >

Want to get in touch? Email us at news@wallstreetzen.com.